Dihexa 10mg

Dihexa is a synthetic research peptide supplied as a lyophilised powder. In published preclinical literature it is commonly described as an angiotensin IV–derived analogue used in controlled experimental settings to explore HGF/c-Met pathway signalling and related neurobiology markers in laboratory and animal models.

Preclinical Focus (Research Context)

In laboratory and animal studies, Dihexa is most commonly explored for neurobiology and synaptic signalling research. Researchers use it in controlled models to observe things like:

• Markers linked to HGF/c-Met signalling activity (a common “target engagement” readout)
• Neurite growth and synapse-related readouts reported in experimental neurobiology models (study-dependent)
• Behavioural and cognitive-style endpoints reported in animal-model study designs, depending on protocol
• Downstream stress/inflammation markers that are sometimes tracked alongside neurobiology research, depending on the study setup

These are preclinical observations and results can vary by model and study design.

Technical Data

• Chemical name: Dihexa (N-hexanoic-Tyr-Ile-Ahx-NH2)
• Synonyms: PNB-0408; N-hexanoic-Tyr-Ile-(6) aminohexanoic amide; Hexanoyl-Tyr-Ile-Ahx-NH2
• Sequence (as commonly listed): Hexanoyl-Tyr-Ile-Ahx-NH2
• Molecular formula: C27H44N4O5
• Molecular weight: 504.7 g/mol
• CAS: 1401708-83-5
• Form: Lyophilised (freeze-dried) powder
• Appearance: White to off-white solid (may vary by batch)

Legal & Safety

This product is supplied strictly for laboratory research purposes. It is not intended for human consumption or veterinary use, and it is not marketed for diagnosis, treatment, or prevention of any disease. No directions for personal use are provided or implied. The purchaser is responsible for ensuring compliant handling, storage, and use in accordance with applicable laws and regulations.